5 August 2024
Hogan Lovells advises Myriad Genetics on reorganization of international business operations and sale of EndoPredict business
Advising firms
Deal team
1 lawyer named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Peter Huber Lead | Hogan Lovells Cadwalader | Partner | Not stated | Not stated |
Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- Not stated
- What the figure measures
- Not stated
- Client
- Myriad GeneticsSell-side
- Counterparties
- Eurobio Scientific (Buy-side)